Immunological Biomarkers in Postinfectious Irritable Bowel Syndrome (Q41172853)

27 September 2017

title

Immunological Biomarkers in Postinfectious Irritable Bowel Syndrome (English)

1 reference

27 September 2017

0 references

Brian L Pike

1 reference

27 September 2017

Katie Ann Paden

1 reference

27 September 2017

Ashley N Alcala

1 reference

27 September 2017

Kayla M Jaep

1 reference

27 September 2017

Robert P Gormley

1 reference

27 September 2017

Alexander C Maue

1 reference

27 September 2017

Benjamin S Christmann

1 reference

27 September 2017

Charles O Elson

1 reference

27 September 2017

Mark S Riddle

1 reference

27 September 2017

Chad K Porter

1 reference

27 September 2017

publication date

8 June 2015

1 reference

Journal of Travel Medicine

27 September 2017

published in

1 reference

27 September 2017

1 reference

27 September 2017

1 reference

27 September 2017

page(s)

242-250

1 reference

The Role of Diagnostic Testing in Irritable Bowel Syndrome

27 September 2017

cites work

1 reference

Functional gastrointestinal disorders as a public health problem

21 January 2018

1 reference

21 January 2018

1 reference

Use of serum biomarkers in a diagnostic test for irritable bowel syndrome

21 January 2018

1 reference

Report from the multinational irritable bowel syndrome initiative 2012.

21 January 2018

1 reference

Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups

21 January 2018

1 reference

Altered levels of fecal chromogranins and secretogranins in IBS: relevance for pathophysiology and symptoms?

21 January 2018

1 reference

An investigation of fecal volatile organic metabolites in irritable bowel syndrome

21 January 2018

1 reference

Abnormal rectal endocrine cells in patients with irritable bowel syndrome

21 January 2018

1 reference

Chromogranin A cell density as a diagnostic marker for lymphocytic colitis

21 January 2018

1 reference

Increased immunoendocrine cells in intestinal mucosa of postinfectious irritable bowel syndrome patients 3 years after acute Shigella infection--an observation in a small case control study

21 January 2018

1 reference

Immune dysfunction in patients with functional gastrointestinal disorders

21 January 2018

1 reference

The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors

21 January 2018

1 reference

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

21 January 2018

1 reference

Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia

21 January 2018

1 reference

Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome

21 January 2018

1 reference

Role of toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the disease subtype

21 January 2018

1 reference

Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.

21 January 2018

1 reference

S100A expression and interleukin-10 polymorphisms are associated with ulcerative colitis and diarrhea predominant irritable bowel syndrome

21 January 2018

1 reference

Brain-derived neurotrophic factor contributes to abdominal pain in irritable bowel syndrome

21 January 2018

1 reference

Serum and colonic mucosal immune markers in irritable bowel syndrome

21 January 2018

1 reference

Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort

21 January 2018

1 reference

Marked elevations in pro-inflammatory polyunsaturated fatty acid metabolites in females with irritable bowel syndrome

21 January 2018

1 reference

Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors

21 January 2018

1 reference

Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?

21 January 2018

1 reference

Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity

21 January 2018

1 reference

Serum leptin levels and irritable bowel syndrome: a new hypothesis

21 January 2018

1 reference

A Distinct Profile of Tryptophan Metabolism along the Kynurenine Pathway Downstream of Toll-Like Receptor Activation in Irritable Bowel Syndrome

21 January 2018

1 reference

Pro-inflammatory chemokine C-C motif ligand 16 (CCL-16) dysregulation in irritable bowel syndrome (IBS): a pilot study

21 January 2018

1 reference

Lower serum IL-10 is an independent predictor of IBS among volunteers in Mexico.

21 January 2018

1 reference

Postinfectious irritable bowel syndrome--a meta-analysis

21 January 2018

1 reference

Estimating the contribution of acute gastroenteritis to the overall prevalence of irritable bowel syndrome

21 January 2018

1 reference

The putative role of the intestinal microbiota in the irritable bowel syndrome

21 January 2018

1 reference

Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

Epithelial crosstalk at the microbiota-mucosal interface.

21 January 2018

1 reference

Gene, environment, and brain-gut interactions in irritable bowel syndrome

21 January 2018

1 reference

Pathogenic mechanisms of postinfectious functional gastrointestinal disorders: results 3 years after gastroenteritis.

21 January 2018

1 reference

The clinical course of postinfectious irritable bowel syndrome: a five-year follow-up study.

21 January 2018

1 reference

Chemotactic chemokines are important in the pathogenesis of irritable bowel syndrome

21 January 2018

1 reference

Immune activation in patients with irritable bowel syndrome

21 January 2018

1 reference

Altered peripheral toll-like receptor responses in the irritable bowel syndrome

21 January 2018

1 reference

Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses

21 January 2018

1 reference

Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives

21 January 2018

1 reference

Infection control in the multidrug-resistant era: tending the human microbiome

21 January 2018

1 reference

Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation

21 January 2018

1 reference

Randomised clinical trial: A liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12 week double-blind study

21 January 2018

1 reference

Invasion of epithelial cells by Campylobacter jejuni is independent of caveolae

21 January 2018

1 reference

An excess of prior irritable bowel syndrome diagnoses or treatments in Celiac disease: evidence of diagnostic delay

21 January 2018

1 reference

Estimating the true incidence of campylobacteriosis and salmonellosis in the European Union, 2009.

21 January 2018

1 reference

Estimated Numbers of Community Cases of Illness Due to Salmonella, Campylobacter and Verotoxigenic Escherichia Coli: Pathogen-specific Community Rates.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JTM.12218

1 reference

27 September 2017

1 reference